Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review
Authors:
- Robin J. BorchertRBRobin J. Borchert
- Tiago AzevedoTiago Azevedo
- AmanPreet BadhwarABAmanPreet Badhwar
- Jose BernalJBJose Bernal
- Matthew BettsMBMatthew Betts
- Rose BruffaertsRBRose Bruffaerts
- Michael C. BurkhartMichael C. Burkhart
- Ilse DewachterIDIlse Dewachter
- Helena M. GellersenHGHelena M. Gellersen
- Audrey LowALAudrey Low
- Ilianna LouridaILIlianna Lourida
- Luiza MachadoLMLuiza Machado
Top Cited Papers
Open Access
- 10 August 2023
- journal article
- review article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (12) , 5885-5904
Abstract
Introduction: Artificial intelligence (AI) and neuroimaging offer new opportunities for diagnosis and prognosis of dementia.Methods: We systematically reviewed studies reporting AI for neuroimaging in diagnosis and/or prognosis of cognitive neurodegenerative diseases.Results: A total of 255 studies were identified. Most studies relied on the Alzheimer's Disease Neuroimaging Initiative dataset. Algorithmic classifiers were the most commonly used AI method (48%) and discriminative models performed best for differentiating Alzheimer's disease from controls. The accuracy of algorithms varied with the patient cohort, imaging modalities, and stratifiers used. Few studies performed validation in an independent cohort.Discussion: The literature has several methodological limitations including lack of sufficient algorithm development descriptions and standard definitions. We make recommendations to improve model validation including addressing key clinical questions, providing sufficient description of AI methods and validating findings in independent datasets. Collaborative approaches between experts in AI and medicine will help achieve the promising potential of AI tools in practice.Highlights: There has been a rapid expansion in the use of machine learning for diagnosis and prognosis in neurodegenerative disease Most studies (71%) relied on the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset with no other individual dataset used more than five times There has been a recent rise in the use of more complex discriminative models (e.g., neural networks) that performed better than other classifiers for classification of AD vs healthy controls We make recommendations to address methodological considerations, addressing key clinical questions, and validation We also make recommendations for the field more broadly to standardize outcome measures, address gaps in the literature, and monitor sources of biasKeywords
Funding Information
- Medical Research Council (MR/X005674/1)
This publication has 137 references indexed in Scilit:
- Predicting Future Clinical Changes of MCI Patients Using Longitudinal and Multimodal BiomarkersPLOS ONE, 2012
- Brain ERP components predict which individuals progress to Alzheimer's disease and which do notNeurobiology of Aging, 2011
- Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairmentNeuroImage, 2011
- A systematic review of ethnicity and pathways to care in dementiaInternational Journal of Geriatric Psychiatry, 2010
- A comparative study of synchrony measures for the early diagnosis of Alzheimer's disease based on EEGNeuroImage, 2010
- Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD indexBrain, 2009
- Structural and functional biomarkers of prodromal Alzheimer's disease: A high-dimensional pattern classification studyNeuroImage, 2008
- Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to ADNeurobiology of Aging, 2006
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CTStroke, 2001